These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9470127)

  • 1. PET and the investigation of dementia in the parkinsonian patient.
    Turjanski N; Brooks DJ
    J Neural Transm Suppl; 1997; 51():37-48. PubMed ID: 9470127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.
    Albin RL; Minoshima S; D'Amato CJ; Frey KA; Kuhl DA; Sima AA
    Neurology; 1996 Aug; 47(2):462-6. PubMed ID: 8757021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Zhao P; Zhang B; Gao S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
    Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M
    Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET patterns associated with underlying pathology in corticobasal syndrome.
    Pardini M; Huey ED; Spina S; Kreisl WC; Morbelli S; Wassermann EM; Nobili F; Ghetti B; Grafman J
    Neurology; 2019 Mar; 92(10):e1121-e1135. PubMed ID: 30700592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
    Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P
    J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
    Amtage F; Hellwig S; Kreft A; Spehl T; Glauche V; Winkler C; Rijntjes M; Hellwig B; Weiller C; Weber WA; Tüscher O; Meyer PT
    Clin Nucl Med; 2014 Apr; 39(4):319-25. PubMed ID: 24566396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
    Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image analysis of neuropil threads in Alzheimer's, Pick's, diffuse Lewy body disease and in progressive supranuclear palsy.
    Davis DG; Wang HZ; Markesbery WR
    J Neuropathol Exp Neurol; 1992 Nov; 51(6):594-600. PubMed ID: 1336541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET and differential diagnosis of dementia.
    Herholz K
    Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of positron emission tomography for diagnosis of dementia.
    Ishii K
    Ann Nucl Med; 2002 Dec; 16(8):515-25. PubMed ID: 12593416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.